Montular Kids of the tab. zhev. 5 mg No. 30

Montular Kids is a medicine, for system application at obstructive respiratory diseases.

Indications

• as additional treatment at bronchial asthma at patients aged from 6 up to 14 years with persistent asthma of easy and average degree which is insufficiently controlled by inhalation GKS and also at insufficient clinical control of asthma by means of agonists of β-adrenoceptors of short action which apply if necessary;
instead of low doses of inhalation corticosteroids inhalation corticosteroids cannot apply
• as an alternative method of treatment to patients aged from 6 up to 14 years with persistent asthma of easy degree at which did not note the serious attacks of bronchial asthma demanding application of oral corticosteroids recently and also;
• prevention of asthma which dominating component is the bronchospasm induced by physical activity at patients aged from 6 up to 14 years.

Structure

• each chewable tablet contains sodium montelukast in terms of montelukast 5 mg;
• cellulose microcrystalline (PH 112), a hydroksipropilmetiltsellyuloza, sodium of a kroskarmelloz, ferrous oxide red (E172), aspartame (E 951), Cherry 501027AP0551 fragrance, attracts (E 421), magnesium stearate.

Contraindication

Hypersensitivity to medicine components.

Recommended dose for children aged from 6 up to 14 years makes

1 chewable tablet (5 mg) a day, apply in the evening. The medicament should be taken in 1 hour prior to food or in 2 hours after a meal. There is no need for dose adjustment for this age group.

Feature of application

Patients should warn that Kids's Montular® for oral administration should not apply to treatment of bad attacks of asthma and also that they have to have always at themselves the corresponding medicine of the emergency help. At a bad attack it is necessary to apply inhalation β-agonists of short action. Patients need to consult as soon as possible with the doctor if to them it is necessary more, than usually, the number of inhalations of β-agonists of short action.

by

risk connected with use of medicine. The available researches have methodological restrictions, including the small size of sample, in certain cases retrospective data collection, and incompatible groups of comparison.

Children

use Drug to children aged from 6 up to 14 years.

Drivers

Montelukast does not influence or has insignificant impact on ability to steer motor transport or other mechanisms. However by patients it was reported about drowsiness or dizziness.

Overdose

Most often observed the side reactions corresponding to a profile of safety of medicine and included an abdominal pain, drowsiness, thirst, a headache, vomiting and psychomotor hyperactivity.

Side effects

from the system of blood and lymphatic system: tendency to strengthening of bleeding, thrombocytopenia.

from the immune system: reactions of hypersensitivity, including anaphylaxis, eosinophilic infiltration of a liver.

from mentality: hallucinations, disorientation, suicide thoughts and behavior (suitsidalnost), obsessivno-compulsive frustration, disfemiya.

from nervous system: dizziness, slackness, paresthesia/hypesthesia, spasms.

to Store

in original packing at a temperature not above 25 °C.

to Store

out of children's reach.